Statistical shape modeling of shape variability of the human distal tibia: implication for implant design of the tibial component for total ankle replacement.
IF 4.3 3区 工程技术Q1 BIOTECHNOLOGY & APPLIED MICROBIOLOGY
{"title":"Statistical shape modeling of shape variability of the human distal tibia: implication for implant design of the tibial component for total ankle replacement.","authors":"Jian Yu, Chengke Li, Jinyang Lyu, Shengxuan Cao, Chao Zhang, Xin Ma, Dahang Zhao","doi":"10.3389/fbioe.2025.1504897","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Understanding the morphological variability of the distal tibia can help design tibial components of total ankle implants. This study aimed to assess the shape variability of the distal tibial bone, utilizing the statistical shape modeling (SSM) technique.</p><p><strong>Methods: </strong>A total of 229 tibial bones were analyzed through CT scans to develop SSM models. Principal component analysis (PCA) was employed to characterize shape variation across the male, female, and overall groups. The geometric parameters of the resected surfaces at the 10-mm level above the distal tibial articular surface were compared.</p><p><strong>Results: </strong>The first seven principal component analysis (PCA) modes accounted for approximately 24.9%-40% of the shape variation, totaling 71.5%-75.6%. Considerable variabilities were observed among these three groups and all principal modes of variation. Notably, the male tibia had a bigger medial malleolus, anterior part of the fibular notch, and posterior malleolus. In the 10-mm resection surface of the distal tibia, anterior-posterior and medial-lateral distances were the main sources of variation. In addition, variations were frequently detected at both the anterior and posterior corners of the fibular notch in the resection surface of the distal tibia.</p><p><strong>Conclusion: </strong>The SSM technique has been shown to be an effective method in finding mean shape and principal variability. Size plays a crucial role in both inter- and intra-groups, and morphological differences vary across different sizes. Therefore, these considerations should be taken into account while designing tibial components for total ankle implants.</p>","PeriodicalId":12444,"journal":{"name":"Frontiers in Bioengineering and Biotechnology","volume":"13 ","pages":"1504897"},"PeriodicalIF":4.3000,"publicationDate":"2025-02-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11903760/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in Bioengineering and Biotechnology","FirstCategoryId":"5","ListUrlMain":"https://doi.org/10.3389/fbioe.2025.1504897","RegionNum":3,"RegionCategory":"工程技术","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"BIOTECHNOLOGY & APPLIED MICROBIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction: Understanding the morphological variability of the distal tibia can help design tibial components of total ankle implants. This study aimed to assess the shape variability of the distal tibial bone, utilizing the statistical shape modeling (SSM) technique.
Methods: A total of 229 tibial bones were analyzed through CT scans to develop SSM models. Principal component analysis (PCA) was employed to characterize shape variation across the male, female, and overall groups. The geometric parameters of the resected surfaces at the 10-mm level above the distal tibial articular surface were compared.
Results: The first seven principal component analysis (PCA) modes accounted for approximately 24.9%-40% of the shape variation, totaling 71.5%-75.6%. Considerable variabilities were observed among these three groups and all principal modes of variation. Notably, the male tibia had a bigger medial malleolus, anterior part of the fibular notch, and posterior malleolus. In the 10-mm resection surface of the distal tibia, anterior-posterior and medial-lateral distances were the main sources of variation. In addition, variations were frequently detected at both the anterior and posterior corners of the fibular notch in the resection surface of the distal tibia.
Conclusion: The SSM technique has been shown to be an effective method in finding mean shape and principal variability. Size plays a crucial role in both inter- and intra-groups, and morphological differences vary across different sizes. Therefore, these considerations should be taken into account while designing tibial components for total ankle implants.
期刊介绍:
The translation of new discoveries in medicine to clinical routine has never been easy. During the second half of the last century, thanks to the progress in chemistry, biochemistry and pharmacology, we have seen the development and the application of a large number of drugs and devices aimed at the treatment of symptoms, blocking unwanted pathways and, in the case of infectious diseases, fighting the micro-organisms responsible. However, we are facing, today, a dramatic change in the therapeutic approach to pathologies and diseases. Indeed, the challenge of the present and the next decade is to fully restore the physiological status of the diseased organism and to completely regenerate tissue and organs when they are so seriously affected that treatments cannot be limited to the repression of symptoms or to the repair of damage. This is being made possible thanks to the major developments made in basic cell and molecular biology, including stem cell science, growth factor delivery, gene isolation and transfection, the advances in bioengineering and nanotechnology, including development of new biomaterials, biofabrication technologies and use of bioreactors, and the big improvements in diagnostic tools and imaging of cells, tissues and organs.
In today`s world, an enhancement of communication between multidisciplinary experts, together with the promotion of joint projects and close collaborations among scientists, engineers, industry people, regulatory agencies and physicians are absolute requirements for the success of any attempt to develop and clinically apply a new biological therapy or an innovative device involving the collective use of biomaterials, cells and/or bioactive molecules. “Frontiers in Bioengineering and Biotechnology” aspires to be a forum for all people involved in the process by bridging the gap too often existing between a discovery in the basic sciences and its clinical application.